europe trip, page-75

Not going to start a new thread for this, but I think its something to ponder or start some discussion.

Just Roche and their take overs is enough to get me thinking


Key Stories
***********

* Roche's $5.7 billion hostile bid to scoop up DNA sequencing
machine maker Illumina (ILMN) has triggered talk of further merger
targets in the promising genomics arena.
And the race to invent faster and cheaper ways of decoding the
genome has pushed small companies to the cutting edge of the field,
giving industry leaders such as Illumina and Life Technologies (LIFE) a
run for their money.
While Swiss drug giant Roche continues its advance to gobble up a
resistant Illumina, analysts have noted that rival Life Technologies
could generate interest from other companies wanting a foothold in the
blossoming market for DNA sequencers, Bloomberg reports.
Genomics touches drug development, diagnostics and basic
research.
Other potential targets could be cancer test maker Genomic Health
and Affymetrics, a maker of gene-analysis products, JMP Securities said,
as quoted by Bloomberg.
(Source: FiercePharma)